Failures halt Phase III trials of infused Alzheimer’s drug
By
Deborah Weinstein
Sep 01, 2012
Pfizer, Johnson & Johnson, and Elan said all Phase III tests of Alzheimer’s drug bapineuzumab are being halted after the drug failed to hit its goals for cognition and global function.
GE, Microsoft to launch health data firm
By
John O'Connor
Feb 01, 2012
Microsoft announced that it will partner with General Electric to form a new company that makes healthcare information more accessible. The partners said they hope to optimize the treatment that healthcare...
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.
Latest dehydration tool is a pressurized fluid reservoir
By
Elizabeth Newman
Jun 05, 2015
Despite dozens of studies on dehydration in the elderly, little research offers conclusive advice on how to solve the problem. A new device hopes to help by using a system that sprays high volumes of fluid...
Groups blast new IRS device tax rules
By
John O'Connor
Jan 02, 2013
Internal Revenue Service guidance released in December spells out how a 2.3% excise tax on medical devices would be carried out.
The acquisition of Vikus Corporation by HealthcareSource has resulted in an integrated platform with plans to continue further investments, HealthcareSource CEO J.P. Fingado said in January. When Fingado...
PharMerica to be acquired by KKR in $1.4B deal; Walgreens will a be minority investor
By
Elizabeth Newman
Sep 06, 2017
Global investment firm KKR will buy PharMerica Corporation in a $1.4 billion deal, the companies announced in August.
Vendors helping nudge HR operations away from paper
By
Elizabeth Newman
Jul 06, 2017
For all the push for providers to move to electronic health records, the process of hiring and onboarding employees still often requires paper.
MS drug Tecfidera approved, awaited
By
Kevin McCaffrey
May 01, 2013
The approval of Biogen Idec’s MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne...
CompanyBriefs
Aug 01, 2013
» Chris Bauleke is the new CEO at Healthland Inc., the company announced at the end of June. Bauleke was previously president of RelayHealth Enterprise Intelligence at McKesson.